HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anastasios Kyriazoglou Selected Research

Anastasios Kyriazoglou Research Topics

Disease

8Neoplasms (Cancer)
06/2022 - 01/2019
4Sarcoma (Soft Tissue Sarcoma)
06/2022 - 12/2018
3Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
06/2022 - 01/2019
3Breast Neoplasms (Breast Cancer)
02/2022 - 12/2019
2Carcinogenesis
06/2022 - 05/2021
2Ovarian Neoplasms (Ovarian Cancer)
04/2022 - 01/2020
2Leiomyosarcoma
05/2021 - 04/2021
2Uterine Cervical Neoplasms (Cancer of the Cervix)
09/2019 - 05/2019
1Renal Cell Carcinoma (Grawitz Tumor)
04/2022
1Disease Progression
04/2022
1Arthralgia (Joint Pain)
04/2022
1Carcinoma (Carcinomatosis)
04/2022
1Nasopharyngeal Carcinoma
12/2021
1Brain Neoplasms (Brain Tumor)
12/2021
1Endometrial Stromal Sarcoma
05/2021
1Osteosarcoma (Osteogenic Sarcoma)
04/2021
1Musculoskeletal Pain
01/2021
1Ovarian Epithelial Carcinoma
01/2020
1Necrosis
01/2020
1Epithelioid Hemangioendothelioma
01/2020
1Spontaneous Abortion (Miscarriage)
09/2019
1Ewing Sarcoma (Sarcoma, Ewing)
06/2019
1Guillain-Barre Syndrome
01/2019
1Lung Neoplasms (Lung Cancer)
04/2018
1Tooth Erosion
07/2014

Drug/Important Bio-Agent (IBA)

3Immune Checkpoint InhibitorsIBA
04/2022 - 01/2021
3Biological ProductsIBA
02/2022 - 01/2019
2cabozantinibIBA
06/2022 - 01/2021
2Proteins (Proteins, Gene)FDA Link
06/2022 - 05/2021
2Cyclin D1IBA
05/2021 - 01/2019
2Imatinib Mesylate (Gleevec)FDA Link
01/2019 - 07/2014
2NivolumabIBA
01/2019 - 04/2018
1Tyrosine Kinase InhibitorsIBA
06/2022
1Adrenal Cortex Hormones (Corticosteroids)IBA
04/2022
1Methotrexate (Mexate)FDA LinkGeneric
04/2022
1Bevacizumab (Avastin)FDA Link
04/2022
1Oncogene Proteins (Oncogene Protein)IBA
05/2021
1Biomarkers (Surrogate Marker)IBA
05/2021
1ripretinibIBA
01/2021
1avapritinibIBA
01/2021
1Aromatase InhibitorsIBA
01/2021
1Hormones (Hormone)IBA
01/2021
1olaratumabIBA
01/2020
1MicroRNAs (MicroRNA)IBA
12/2019
1Taxoids (Taxanes)IBA
09/2019
1PlatinumIBA
09/2019
1Pharmaceutical PreparationsIBA
01/2019
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2019
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019
1pembrolizumabIBA
04/2018
1atezolizumabIBA
04/2018
1ErbB Receptors (EGF Receptor)IBA
04/2018
1AfatinibIBA
04/2018
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2018
1RamucirumabIBA
04/2018
1necitumumabIBA
04/2018
1130-nm albumin-bound paclitaxelIBA
04/2018
1durvalumabIBA
04/2018
1Erlotinib Hydrochloride (CP 358,774)FDA Link
04/2018

Therapy/Procedure

10Therapeutics
04/2022 - 07/2014
7Drug Therapy (Chemotherapy)
06/2022 - 04/2018
5Immunotherapy
02/2022 - 04/2018
3Radiotherapy
04/2021 - 06/2019
1Neoadjuvant Therapy
01/2020
1Palliative Care (Palliative Therapy)
12/2018